Watson Recalls Caziant Tablets Due to High Impurity Levels
Watson Laboratories is recalling Caziant tablets because high levels of impurities were detected. Consumers should stop using the product and contact their healthcare provider.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class III recall, which is typically a low-risk issue. The hazard involves impurities, but the agency's classification suggests it is unlikely to cause serious harm, fitting the Moderate category for minor quality deviations.
Plain-English summary
Watson Laboratories, Inc. is recalling 18,938 cartons of Caziant (desogestrel and ethinyl estradiol) Tablets, USP. The recall involves specific lots (412572A and 412572B) with an expiration date of 11/12. The product was distributed nationwide.
The recall was initiated because high out-of-specification results were obtained for both known and unknown impurities. This indicates that the tablets contained degradation products or impurities at levels exceeding the acceptable standards.
Consumers who have this product should stop using it and contact their healthcare provider for further instructions. The FDA has classified this recall as Class III, which means it is not likely to cause adverse health consequences.
The recalled product
- Product
- Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Wa
- Manufacturer
- Watson Laboratories Inc
- Category
- Drug — Oral Contraceptive
- Affected units
- 18,938
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #s: 412572A
- 412572B
- Exp 11/12
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Watson Laboratories Inc
See all →- ModerateWatson Recalls Hydrocodone and Acetaminophen Tablets Due to Broken Tablets
FDA (Drugs) · 2014-02-05
- SevereWatson Recalls Carisoprodol Tablets Due to Metal Particulates
FDA (Drugs) · 2014-01-15
- ModerateWatson Recalls Next Choice Emergency Contraceptive Tablets Due to Breakage
FDA (Drugs) · 2013-10-16
- SevereWatson Recalls Oxycodone and Acetaminophen Tablets Due to Foreign Contamination
FDA (Drugs) · 2013-10-09
- LowWatson Recalls Hydrocodone and Acetaminophen Tablets Due to Defective Seals
FDA (Drugs) · 2013-09-25
Same hazard · impurities
See all →- LowDabigatran Etexilate Capsules Recalled Due to Impurity Specification Failure
FDA (Drugs) · 2026-08-05
- ModerateGlycopyrrolate Oral Solution Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-29
- ModerateMethohexital Sodium for Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-07-15
- ModerateMethohexital Sodium 100 mg/10 mL Compounded Drug Recalled Nationwide
FDA (Drugs) · 2026-07-15
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08